my personal edition > contraception > news
E-Mail this DGNews to a colleague
DGNews
FDA Approves New Oral Contraceptive Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets)
First Birth Control Pill to Provide 24 Days of Active Hormonal Therapy
ROCKAWAY, NJ -- February 20, 2006 -- Warner Chilcott announced that the U.S. Food and Drug Administration (FDA) has approved its 24-day oral contraceptive, Loestrin(R) 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), for the prevention of pregnancy.
Loestrin 24 Fe ("Loestrin 24") is the first birth-control pill approved in the United States that provides 24 days of active hormonal therapy and four days of iron containing placebo pills.
"This FDA approval is a significant step forward for Warner Chilcott as we continue to sharpen our therapeutic focus on women's health and expand our product portfolio in this area," said Roger Boissonneault, Chief Executive Officer of Warner Chilcott.
SOURCE: Warner Chilcott
All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.
| 
